Nav: Home

Common medication used in pregnancy may lead to obesity in children

March 27, 2019

Metformin is often used during pregnancy where the mother is suffering from polycystic ovary syndrome (PCOS). A study from the Norwegian University of Science and Technology (NTNU) has recently shown that this results in fewer miscarriages and premature births.

But a companion Norwegian study shows that children who are exposed to metformin in the womb may later have a higher risk of obesity.

"We can't rule out that these children may have more health problems as adults," says PhD candidate Liv Guro Engen Hanem at NTNU's Department of Clinical and Molecular Medicine.

Hanem is the first author of an article published in the The Lancet Child & Adolescence Health journal.

The results are contrary to the researchers' original hypothesis. They assumed that the children would have a lower risk of obesity later, due to better growth conditions in utero.

Millions of pregnant women use metformin, partly due to PCOS but most often to treat gestational diabetes. Few negative side effects have been demonstrated from its use, and none for the foetus. But so far we know little about possible long-term effects.

The results show that 8-year-old children who were exposed to metformin in utero (in the womb) on average had a higher body mass index (BMI) and waist circumference compared to children of women in a control group. This control group was given an inactive placebo instead.

A higher BMI can lead to negative effects for children later in life from obesity-related ailments.

Children born to mothers with PCOS but not exposed to metformin did not have elevated BMI, weight or height.

These children, when measured as 8-year-olds, however, did have a larger waist circumference as compared to children with mothers who did not have PCOS. Larger waist circumference is associated with an unfavourable distribution of body fat.

The article concludes by noting that the benefits of metformin use in pregnancy must be weighed against these possible long-term health problems in the offspring.

The research group examined 257 pregnant women (274 pregnancies) with PCOS during the period 2005 to 2009. The women received metformin or a placebo during pregnancy.

Researchers conducted follow-up measurements of height, weight, BMI and abdominal circumference on 141 of these children when they were 5 to 10 years old.

Metformin-exposed children were compared with placebo-exposed children. The researchers compared the placebo-exposed children (of mothers with PCOS) with children from a Norwegian reference population.
-end-
Hanem's head supervisor was Professor Eszter Vanky, and co-supervisor was Associate Professor Rønnaug Ødegård, both of Department of Clinical and Molecular Medicine/NTNU. Hanem's research work extended the PregMet1 study and was funded by the Research Council of Norway, St. Olav's Hospital, NTNU and Novo Nordisk.

Reference: Liv Guro Engen Hanem MD, Øyvind Salvesen PhD, Petur BJuliusson MD et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial. The Lancet Child & Adolescent Health. Volume 3, Issue 3, March 2019, Pages 166-174. https://doi.org/10.1016/S2352-4642(18)30385-7

Norwegian University of Science and Technology

Related Obesity Articles:

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.
Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).
How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.
Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?
Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.
Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.
Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.
Systematic review shows risk of a child developing overweight or obesity is more than trebled by maternal obesity prior to pregnancy
New research presented at this year's European Congress on Obesity (ECO) in Glasgow, Scotland (April 28- May 1) reveals that the risk of a child becoming overweight or obese is more than trebled by maternal obesity prior to getting pregnant.
Eating later in the day may be associated with obesity
Eating later in the day may contribute to weight gain, according to a new study to be presented Saturday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.
How obesity affects vitamin D metabolism
A new Journal of Bone and Mineral Research study confirms that vitamin D supplementation is less effective in the presence of obesity, and it uncovers a biological mechanism to explain this observation.
More Obesity News and Obesity Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Space
One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at Radiolab.org/donate.